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access when the basilic vein is absent in patients with difficult access extrem-
ities. Most patients required one or more interventional procedures. Cumu-
lative (secondary) patency was 91.7% at 24 months.
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Fenestrated and Branched Endograft Repair of Juxta- and Para-renal
Aneurysms after Previous Open Aortic Reconstruction
Adam W. Beck1,2, Wendy T. G. Bos2, Georgios Vourliotakis23, Clark J.
Zeebregts2, Ignace F. J. Tielliu2, Eric L. G. Verhoeven2. 1Dartmouth-
HitchcockMedical Center,West Lebanon, NH; 2UniversityMedical Center
of Groningen, Groningen, TheNetherlands, Netherlands; 3GeneralMilitary
Hospital of Athens, Athens, Greece, Greece
Objective: Para-anastomotic aneurysms and progressive aneurysmal
degeneration after previous open aortic reconstruction pose a difficult
scenario. Due to proximity to the visceral arteries, endovascular exclusion is
typically not an option. Fenestrated and branched endografts provide a less
invasive means of repair. We sought to evaluate our experience with fenes-
trated endografts in the management of juxta- and para-renal aneurysms
after previous open reconstruction.
Methods: This analysis was based on a prospective database gathered
from March 2004 to November 2008. Patients underwent repair under the
direction of a single surgeon using customized Cook endografts manufac-
tured based on preoperative imaging.
Results: 18 patients were treated over the study interval. All patients
had a previous open aortic reconstruction. Mean time since the operation
was 8.5 years (range 1 to 15 years). Mean patient age was 72 years (range 57
to 80 years). All patients were considered high risk for open surgery due to
co-morbidities and/or the redo nature of their surgery. The mean number
of fenestrations per patient was 3, including proximal graft scallops. All but
one (94%) was completed by totally endovascular means. One operation
required a planned celiotomy for retrograde access to a left renal artery. Of
56 target vessels, all were successfully re-vascularized with a combination of:
fenestrations with bare metal (12) or covered stents (25), as well as graft
branches (1), or graft scallops (18). Mean operative time was 215 minutes
(range 135-420 minutes) and mean blood loss was 560cc (range 100 to
1500cc). 30-day and 1-year mortality was 0 and 11%, respectively. Peri-
operative complications occurred in 2 patients. One developed a congestive
heart failure exacerbation and myocardial infarction and one a groin wound
infection. Mean follow-up time was 23 months and cumulative primary
patency was 95% (53/56 vessels), with no follow-up interventions required.
Conclusions: Endovascular treatment of juxta- and para-renal aneu-
rysms after prior aortic reconstruction is a viable alternative to open repair
with high success and low re-intervention rates. These devices will broaden
the available treatment modalities for these conditions, and will likely
decrease the complication rate of treatment in these high-risk patients.
Author Disclosures: A.W. Beck, None; W.T.G. Bos, None; G. Vourlio-
takis, None; C.J. Zeebregts, None; I.F.J. Tielliu, None; E.L.G. Verhoeven,
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30 Day Mortality From Reintervention or Readmission Following
Endovascular and Open Repair of Abdominal Aortic Aneurysms in the
United States Medicare Population
Marc L Schermerhorn1, Kristina A Giles1, A James O’Malley2, Philip
Cotterill2, Frank B Pomposelli1, Bruce E Landon2. 1Beth Israel Deaconess
Medical Center, Boston, MA; 2Harvard Medical School, Boston, MA
Objective: Late survival is similar after EVAR and open AAA repair
(OAR) despite a perioperative benefit with EVAR. AAA-related reinterven-
tions are more common after EVAR while laparotomy related reinterven-
tions are more common after OAR. The impact of reinterventions on
survival, however, is unknown.
Methods: Using propensity score matched Medicare beneficiaries
(n45,652) undergoing EVAR and OAR from 2001-2004, AAA and
laparotomy-related reinterventions through 2006 were identified. A hierar-
chical severity scheme was utilized within each hospitalization to avoid
counting multiple adjunctive procedures. Hospitalizations for ruptured
AAA without repair and for bowel obstruction or ventral hernia without
abdominal surgery as well as amputations were also recorded. 30 day
mortality was calculated for each reintervention or readmission.Results: Overall reinterventions or readmissions were similar between
repair methods but slightly more common after EVAR (Table). EVAR patients
had more ruptures (mortality 27%). EVAR patients also had more AAA-related
reinterventions (mortality 5.6%), the majority of which were minor endovascu-
lar reinterventions (mortality 3.0%).However,minor open (mortality 6.9%) and
major reinterventions (mortality 12.1 %) were also more common after EVAR
than open repair. OAR patients had more laparotomy related reinterventions
(mortality 8.1%) and readmissions without surgery (mortality 10.9%). Overall
30 daymortality after any reintervention or readmission was higher after EVAR
than OAR (9.8% vs 7.5%, p0.001).
Conclusion: Overall reintervention and readmission, and their associ-
ated 30 day mortality, are higher after EVAR with up to 6 years of follow-up
which likely contributes to loss of late survival benefit after EVAR.
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Iliac Branched Devices: Technical Aspects and Midterm Patency
Marcelo Ferreira, Luiz Lanziotti, Marcelo Monteiro. SITE - Rio de Janeiro,
Rio de Janeiro, Brazil
Objective: This study presents technical aspects, midterm results and
complications using iliac bifurcation devices (IBD) and determine its feasi-
bility and safety in patients with aortoiliac or common iliac artery aneurysms
(CIAA), including those with bilateral disease. METHODS: Since 2006, 47
IBD were implanted in 37 patients and followed for a meanSD of 11,6
7,5 months (range 2 to 31).Treated CIAA were unilateral in 27 patients and
bilateral in 10. Two patients with bilateral CIAA did not have simultaneous
aortic aneurysm and one had an anastomotic pseudoaneurysm. Two patients
underwent combined thoracoabdominal aneurysm treatment with branched
endografts and one underwent combined juxta-renal aneurysm repair with a
fenestrated device. Eleven (23,4%) CIAA received the Helical Iliac Side
Branch device and the remaining 36 (76,6%) received the Zenith Bifurcated
Iliac Sidebranch.
Results: Technical success was 97,3% of 47 intended to treat CIAA
(migration failure in one patient). There were no deaths and no conversions
to open repair. During follow-up five (10,6%) hypogastric branch occlusions
occurred in five patients, all within the first 12 months, and one patient
developed persistent buttock claudication. Two unilateral occlusions oc-
curred in patiens with bilateral repair, sparring the contralateral CIA. No
endoleak, modular side branch disconnection or late iliac rupture were
observed. Cumulative patency was 74% up to 31 months.
Conclusions: Bilateral CIAA treatment with IBD should be consid-
ered standard treatment for bilateral disease.The use of IBD to preserve
pelvic circulation is safe and feasible for most patients CIAA, including
those with concomitant Abdominal or Thoracoabdominal Aortic Aneu-
rysms.
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Ruptured Abdominal Aortic Aneurysm: The Harborview Experience-
Part 2
Benjamin W Starnes, Elina Quiroga, Nam T. Tran, Thomas Hatsukami,
Mark Meissner, Ted Kohler, Michael Sobel. University of Washington,
Seattle, WA
Objectives: Our institution treats between 30 and 50 patients per year
with ruptured abdominal aortic aneurysm (rAAA) and our overall 30-day
mortality between 2002 and 2007 averaged 60%. We sought to evaluate the
effect on mortality of the implementation of an algorithm to manage these
patients with a preference for endovascular aneurysm repair (EVAR) when
feasible.
Methods: Patients presenting with rAAA between July 1, 2002 and
June 30, 2007 served as retrospective controls. The treatment group con-
sisted of patients presenting after July 1, 2007, who were treated with a
structured protocol including early proximal control with an aortic occlusion
balloon, permissive hypotension, and endovascular repair when possible.
The primary outcome measure was 30-day mortality. Data were analyzed
using Chi Square and Fisher’s Exact Test where appropriate.
Results: The 30-day mortality for the 131 control patients was 60%.
After implementation of the protocol, 50 patients with rAAAweremanaged.
Eighteen (36%) underwent successful EVAR, and twenty-eight (46%) un-
derwent open repair. Four patients (8%) received comfort care only. Three
patients in the EVAR group (17%) and thirteen patients in the open group
(46%) died during the follow up period for an overall 30-day mortality rate
of 35% (p0.006 vs 60% of controls). There was no difference in the
incidence of hypotension on presentation (SBP80mmHg) between con-
trol (65%) and treatment (61%) groups. In the treatment group, 28/46
(61%) presented with hypotension. The incidence of hypotension between
open and EVAR patients did not differ in the treatment group. Average
transfusion requirement for those undergoing EVAR was 1 unit (0-13) and
for open repair, 8 units (0-19). The difference in transfusion requirement
amongst survivors in each group was not different (p 0.06).
Conclusions: An algorithm using early proximal aortic control with a
balloon catheter, permissive hypotension, and endovascular repair when
possible reduced rAAA mortality by 40% (absolute risk reduction of 25%).
Using this approach in a large, urban hospital, the majority of patients
presenting with rAAA survived. Further reduction in mortality is expected as
improvement in endovascular techniques allows treatment of more patients
with complex aortic anatomy.
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Implications of Endoleaks on Aneurysm Sac Pressures Following En-
dovascular Repair of Elective and Ruptured Aortic Aneurysms
Manish Mehta, John B Taggert, Sean P Roddy, Yaron Sternbach, Paul B
Kreienberg, Ashik Desai, Philip S K Paty, Kathleen J Ozsvath, Benjamin B
Chang, Dhiraj M Shah, R Clement Darling, III. Albany Medical College,
Albany, NYPurpose: To analyze the implications of endoleaks on sac pressures
following endovascular aneurysm repair (EVAR) of elective and ruptured
abdominal aortic aneurysms (AAA).
Methods: Since 2006, 480 patients underwent EVAR and simulta-
neous placement of the cardioMEMS Endosure® wireless pressure sensor in
the excluded aneurysm sac for elective (n455, 94%) and ruptured (n25,
6%) AAA. Aneuryms sac pressures were measured prior and subsequent to
completion of stentgraft placement, at 1 month, and every 6 months
thereafter. Patients were also followed-up by CTA at 6-12 month intervals,
and evaluated for the presence of endoleaks. All patients with type I
endoleaks were treated at the time of diagnosis, patients with type II
endoleaks at 6 months without decrease in aneurysm size were treated by
coil embolization. The ratio of sac to systemic pressure was used to create a
standardized pressure index for systolic pressures (SPI), diastolic pressures
(DPI), mean (MPI), and pulse pressures (PPI).
Results: At postoperative time intervals ranging from 1 day to 24
months, in patients with No Endoleak (n364, 76%), there were no
significant differences in any of the mean pressure indexes, and all indexes
decreased at 2 wks; SPI (0.09), DPI (0.2), MPI (0.12), and PPI (0.03). In
patients with Type II Endoleak (n102, 21%), there were marked elevations
in all mean pressure indexes when compared to No Endoleak group. In this
group, all indexes were higher than in patients without endoleak up to 6
months; SPI (0.30), DPI (0.46), MPI (0.38), and PPI (0.2). Treatment of
Type II endoleaks lead to a significant reduction in these indexes; SPI (0.08),
DPI (0.18),MPI (0.12), and PPI (0.02). Patients with Type I endoleaks had
consistent elevation in all pressure indexes that approximated pre-exclusion
aneurysm sac pressures; SPI (0.8), DPI (1.20), MPI (0.92), and PPI (0.42)
and these indexes decreased significantly following treatment of the type I
endoleaks. There was no difference in sac pressures in any group when
comparing EVAR for elective vs. ruptured AAA.
Conclusions: Presence of Type I and II endoleaks can be predicted on
by evaluating aneurysm sac pressures; the DPI and MPI are significantly
elevated in presence of Type I and II endoleaks. Successful treatment of
endoleaks can be predicted by decrease in aneurysm sac pressures.
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Asymptomatic Perioperative Myocardial Damage is Associated with
Poor Long-term Outcome after Vascular Surgery
Olaf Schouten1, Tamara A Winkel1, Gijs MJM Welten1, Hero van Urk1,
Hence JMVerhagen1, Jeroen J. Bax2, Don Poldermans1. 1ErasmusMedical
Center Rotterdam, Rotterdam, Netherlands; 2Leiden University Medical
Center, Leiden, Netherlands
Background: Cardiac troponin T (cTnT) release is a sensitive marker
for myocardial injury and occurs frequently after vascular surgery. However,
the prognosis of cTnT elevations without clinical symptoms and/or new
electrocardiographic changes (asymptomatic cTnT release) is unknown.
Aim: To assess the long-term prognosis of vascular surgery patients
who experience perioperative asymptomatic myocardial damage.
Methods:A total of 1545 patients undergoing elective vascular surgery
were enrolled. Baseline characteristics and medication were noted. Routine
sampling of cTnT and ECG recording was performed on day 1, 3, and 7 after
surgery and at the day of discharge. Elevated cTnT was defined as serum
concentrations  0.01 ng/ml. The mean follow-up was 3.7 years and
mortality was noted.
Results:A total of 213 (14%) patients experienced asymptomatic cTnT
release, median 0.08 ng/ml (IQR 0.04-0.20 ng/ml), while 71 (5%) patients
had symptomatic cTnT release. During follow-up 304 patients (20%) died.
Mortality was higher in patients with asymptomatic cTnT release compared
to patients without cTnT release (13% vs. 40%; p0.001, figure). After
adjustment for risk factors and type and site of surgery, the association
between asymptomatic elevated cTnT levels and increased late mortality
persisted (adjusted HR 2.3; 95% CI 1.8-3.0) and risk increased with higher
cTnT levels (HR 1.64 for every 0.10 ng/ml increase, p0.02). Elevated
cTnT had prognostic value irrespective of baseline creatinine value or renal
dysfunction after surgery.
Conclusions: Asymptomatic cTnT release, without clinical symptoms
or new ECG changes, is associated with an increased long-term mortality in
patients undergoing vascular surgery.
